The genetics of functional disability in schizophrenia and bipolar illness: Methods and initial results for VA cooperative study #572

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 165, Issue 4, 2014, Pages 381-389

  Harvey, Philip D ^a,b   Siever, Larry J ^c,d   Huang, Grant D ^c   Muralidhar, Sumitra ^c   Zhao, Hongyu ^e,f   Miller, Perry ^e,f   Aslan, Mihaela ^e,f   Mane, Shrikant ^f   Mcnamara, Margaret ^c,d   Gleason, Theresa ^c   Brophy, Mary ^g,h   Przygodszki, Ronald ^c   O'Leary, Timothy J ^c   Gaziano, Michael ^g,i   Concato, John ^e,f  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g Massachusetts Area Veterans Epidemiology Research Information Center (MAVERIC)   (United States)

^h BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ HARVARD UNIVERSITY   (United States)

Author keywords

Bipolar; Disability; Genetics; Neurocognition; Schizophrenia

Indexed keywords

ADULT; ARTICLE; BIPOLAR DISORDER; BIPOLAR I DISORDER; COMORBIDITY; CONTROLLED STUDY; DISABILITY; FEMALE; FUNCTIONAL STATUS; GENETIC ANALYSIS; GENETICS; GENOMICS; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MIDDLE AGED; NEGATIVE SYNDROME; NEUROPSYCHOLOGICAL TEST; OBSERVATIONAL STUDY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SUICIDAL BEHAVIOR; VETERAN; COOPERATION; DEMOGRAPHY; GENETIC PREDISPOSITION; PATHOPHYSIOLOGY; PSYCHOLOGY;

BIPOLAR DISORDER; COOPERATIVE BEHAVIOR; DEMOGRAPHY; DISABILITY EVALUATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SCHIZOPHRENIA; VETERANS;

EID: 84901652450     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32242     Document Type: Article

References (36)

1. Bowie CR, Depp C, McGrath JA, Wolyniec P, Mausbach BT, Thornquist MH, Luke J, Patterson TL, Harvey PD, Pulver AE. 2010. Prediction of real-world functional disability in chronic mental disorders: A comparison of schizophrenia and bipolar disorder. Am J Psychiatry 167:1116-1124.
2. Braff DL, Freedman R, Schork NJ, Gottesman II. 2007. Deconstructing schizophrenia: An overview of the use of endophenotypes in order to understand a complex disorder. Schizophr Bull 33:21-32.
3. Burdick KE, Goldberg TE, Cornblatt VA, Keefe RS, Copin CB, Derosse P, Braga RJ, Malhotra AK. 2011. The MATRICS consensus cognitive battery in patients with bipolar I disorder. Neuropsychopharmacology 36:1587-1592.
4. First MB, Spitzer RL, Gibbon M, Williams JBW. 1995. User's guide for the structured clinical interview for DSM-IV Axis I (SCID-I). Washington, DC: American Psychiatric Press.
5. Greenwood TA, Braff DL, Light GA, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Green MF, Gur RE, Gur RC, Mintz J, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Schork NJ. 2007. Initial heritability analyses of endophenotypic measures for schizophrenia: The consortium on the genetics of schizophrenia. Arch Gen Psychiatry 64:1242-1250.
6. Greenwood TA, Lazzeroni LC, Murray SS, Cadenhead KS, Calkins ME, Dobie DJ, Green MF, Gur RE, Gur RC, Hardiman G, Kelsoe L, Leonard S, Light GA, Nuechterlein KH, Olincy A, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Freedman R, Braff DL. 2011. Analysis of 94 candidate genes and twelve endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry 168:930-946.
7. Gur RE, Calkins ME, Gur RC, Horan WP, Nuechterlein KH, Seidman LJ, Stone WS. 2007. The consortium on the genetics of schizophrenia: Neurocognitive endophenotypes. Schizophr Bull 33:49-68.
8. Harvey PD, Keefe RSE. 2012. Technology, society, and mental illness: Challenges and opportunities for assessment and intervention. Innov Clin Neurosci 9:47-50.
9. Harvey PD, Helldin L, Bowie CR, Heaton RK, Olsson AK, Hjärthag F, Norlander T, Patterson TL. 2009. Performance-based measurement of functional disability in schizophrenia: A cross-national Study in the United States and Sweden. Am J Psychiatry 166:821-827.
10. Harvey PD, Wingo AP, Burdick KE, Baldessarini RJ. 2010. Cognition and disability in bipolar disorder: Lessons from schizophrenia research. Bipolar Disord 12:364-375.
11. Harvey PD, Raykov T, Twamley EW, Vella L, Heaton RK, Patterson TL. 2011. Validating the measurement of real-world functional outcome: Phase I results of the VALERO study. Am J Psychiatry 168:1195-1201.
12. Harvey PD, Heaton RK, Carpenter WT, Green MF, Gold JM, Schoenbaum M. 2012. Diagnosis of schizophrenia: Consistency across information sources and stability of the condition. Schizophr Res 140:9-14.
13. Harvey PD, McClure MM, Patterson TL, McGrath JA, Pulver AE, Bowie CR, Siever LJ. 2012. Impairment in functional capacity as an endophenotype candidate in severe mental illness. Schizophr Bull 38:1318-1326.
14. Harvey PD, Raykov T, Twamley EW, Vella L, Heaton RK, Patterson TL. 2013. The factor structure of neurocognition and functional capacity in schizophrenia: A multidimensional examination of temporal stability. J Int Neuropsychol Soc 19:656-663.
15. Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, McCutchan JA, Reicks C, Grant I, HNRC Group. 2004. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc 10:317-331.
16. Ho BC, Andreasen N, Flaum M. 1997. Dependence on public financial support early in the course of schizophrenia. Psychiatr Serv 48:948-950.
17. Keefe RS, Bilder RM, Harvey PD, Davis SM, Palmer BW, Gold JM, Herbert YM, Green MF, Miller DD, Canive JM, Adler LW, Manschreck TC, Swartz M, Rosenheck R, Perkins DO, Walter TM, Stroup TS, McEvoy JP, Lieberman JA. 2006. Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology 31:2033-2046.
18. Keefe RSE, Fox KH, Harvey PD, Cucchiaro J, Siu C, Loebel A. 2011. Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial. Schizophr Res 125:161-168.
19. Kendler KS, McGuire M, Gruenberg AM, Walsh D. 1995. Schizotypal symptoms and signs in the Roscommon Family Study: Their factor structure and familial relationship with psychotic and affective disorders. Arch Gen Psychiatry 52:296-303.
20. Kern RS, Nuechterlein KH, Green MF, Baade LE, Fenton WS, et al. 2008. The MATRICS Consensus Cognitive Battery: Part 2. Co-norming and standardization. Am J Psychiatry 165:214-220.
21. Kieseppä T, Partonen T, Haukka J, Kaprio J, Lönnqvist J. 2004. High concordance of bipolar I disorder in a nationwide sample of twins. Am J Psychiatry 10:1814-1821.
22. Kotwicki R, Harvey PD. 2013. Systematic study of structured diagnostic procedures in outpatient psychiatric rehabilitation: A three year, three cohort study of the stability of psychiatric diagnoses. Innov Clin Neurosci 10:14-19.
23. Lichtenstein P, Yip BH, Björk C, Pawitan Y, Cannon TD, Sullivan PF, Hultman CM. 2009. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: A population-based study. Lancet 373:234-239.
24. Mausbach BT, Harvey PD, Goldman SR, Jeste DV, Patterson TL. 2007. Development of a brief scale of everyday functioning in persons with serious mental illness. Schizophr Bull 33:1364-1372.
25. McGrath JA, Avramopoulos D, Lasseter VK, Wolyniec PS, Fallin MD, Liang KY, Nestadt G, Thornquist MH, Luke JR, Chen PL, Valle D, Pulver AE. 2009. Familiality of novel factorial dimensions of schizophrenia. Arch Gen Psychiatry 66:591-600.
26. McIntosh BJ, Zhang XY, Kosten T, Tan SP, Xiu MH, Harvey PD. 2011. Performance based assessment of functional skills in severe mental illness: Results of a large-scale study in China. J Psychiatr Res 45:1089-1094.
27. Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, Essock S, Fenson WS, Frese FJ III, Gold JM, Goldberg T, Heaton RK, Keefe RS, Kraemer H, Mesholam-Gately R, Seidman LJ, Stover E, Weinberger DR, Young AS, Zalcman S, Marder SR. 2008. The MATRICS Consensus Cognitive Battery, part 1: Test selection, reliability, and validity. Am J Psychiatry 165:203-213.
28. Nuechterlein KH, Green MF. 2009. The MATRICS Consensus Cognitive Battery (MCCB) administration and Scoring manual. MATRICS Assessment, Inc.
29. Posner K, Oquendo MA, Gould M, Stanley B, Davies M. 2007. Columbia classification algorithm of suicide assessment (C-CASA): Classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Am J Psychiatry 164:1035-1043.
30. Robinson DG, Woerner MG, McMeniman M, Mendelowitz A, Bilder RM. 2004. Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 161:473-479.
31. Sheehan DV, Lecrubier Y, Harnett-Sheehan K, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar G. 1998. The Mini International Neuropsychiatric Interview (M. I.N.I.): The development and validation of a structured diagnostic psychiatric interview. J Clin Psychiatry 59:22-33.
32. Sprangers MAG, Sloan JA, Veenhoven R, Cleeland CS, Halyard MY, Abertnethy AP, Baas F, Barsevick AM, Bartels M, Boomsma DI, Chauhan C, Dueck AC, Frost MH, Hall P, Klepstad P, Martin NG, Miaskowski C, Mosing M, Movsas B, van Noorden CJ, Patrick DL, Pedersen NL, Ropka ME, Shi Q, Shinozaki G, Singh JA, Yang P, Zwinderman AH. 2009. The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes. Twin Res Hum Genet 12(3):301-311.
33. Sullivan PF, Kendler KS, Neale MC. 2003. Schizophrenia as a complex trait: Evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 60:1187-1192.
34. Tohen M, Zarate CA Jr, Hennen J, Khalsa HM, Strakowski SM, Gebre-Medhin P, Salvatore P, Baldessarini RJ. 2003. The McLean-Harvard First-Episode Mania Study: Prediction of recovery and first recurrence. Am J Psychiatry 160:2099-2107.
35. Wingo AP, Harvey PD, Baldessarini RJ. 2009. Neurocognitive impairment in bipolar disorder patients: Functional implications. Bipolar Disord 11:113-125.
36. Wu EQ, Birnbaum HG, Shi L, Ball DE, Kessler RC, Moulis M, Aggarwal J. 2005. The economic burden of schizophrenia in the United States in 2002. J Clin Psychiatry 66:1122-1129.